Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2014

01-11-2014 | Original Article

Fructus Ligustri Lucidi (FLL) ethanol extract increases bone mineral density and improves bone properties in growing female rats

Authors: Ying Lyu, Xin Feng, Pengling Zhao, Zhenghao Wu, Hao Xu, Yuehui Fang, Yangfeng Hou, Liya Denney, Yajun Xu, Haotian Feng

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2014

Login to get access

Abstract

Osteoporosis is a chronic disease affecting millions of people worldwide. It is generally accepted that acquisition of a high peak bone mass (PBM) early in life can reduce the risk of osteoporosis later in life. The aims of this study were to investigate the effects of Fructus Ligustri Lucidi (FLL) ethanol extract on bone mineral density and its mechanical properties in growing female rats and to explore the underlying mechanisms. The rats were given different doses of FLL extract mixed with AIN-93G formula (0.40, 0.65 and 0.90 %), and a group given AIN-93G diet treatment only was used as control. The intervention lasted for 16 weeks until the animals were about 5 months old, the time when the animals almost reach their PBM. Our results showed that FLL treatment increased bone mineral density and improved bone mechanical properties in the growing female rats in a dose-dependent manner. In addition, FLL treatment significantly decreased the serum bone-resorbing marker, CTX-I, while significantly increasing serum 25(OH)D3 and thereby increasing Ca absorption and Ca retention. Intriguingly, both in vivo and in vitro results demonstrated that FLL treatment could reduce the RANKL/OPG ratio. In conclusion, FLL ethanol extract exerted beneficial effects on peak bone mass acquisition and the improvement of bone mechanical properties by favoring Ca metabolism and decreasing the RANKL/OPG ratio.
Literature
1.
go back to reference WHO (2003) Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 921:1–164 WHO (2003) Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 921:1–164
2.
go back to reference NIH (2001) NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7–29, 2000: highlights of the conference. South Med J 94:569–573 NIH (2001) NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7–29, 2000: highlights of the conference. South Med J 94:569–573
3.
go back to reference Brunader R, Shelton DK (2002) Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician 65:1357–1364PubMed Brunader R, Shelton DK (2002) Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician 65:1357–1364PubMed
4.
go back to reference Xue K, Ren-hui L, Xiu-juan W (2012) Advances on studies of anti-osteoporosis applications and mechanisms by Herba Epimedii and Fructus ligustri lucidi. Chin J Exp Tradit Med Formulae 18:331–334 Xue K, Ren-hui L, Xiu-juan W (2012) Advances on studies of anti-osteoporosis applications and mechanisms by Herba Epimedii and Fructus ligustri lucidi. Chin J Exp Tradit Med Formulae 18:331–334
5.
go back to reference Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS (2006) Effects of Fructus ligustri lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29:291–296PubMedCrossRef Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS (2006) Effects of Fructus ligustri lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29:291–296PubMedCrossRef
6.
go back to reference Zhang Y, Dong XL, Leung PC, Che CT, Wong MS (2008) Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause 15:558–565PubMedCrossRef Zhang Y, Dong XL, Leung PC, Che CT, Wong MS (2008) Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause 15:558–565PubMedCrossRef
7.
go back to reference Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus ligustri lucidi. Br J Nutr 99:494–502PubMed Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus ligustri lucidi. Br J Nutr 99:494–502PubMed
9.
go back to reference Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–S11PubMedCrossRef Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–S11PubMedCrossRef
10.
go back to reference Peterson CA, Eurell JA, Erdman JJ (1995) Alterations in calcium intake on peak bone mass in the female rat. J Bone Miner Res 10:81–95PubMedCrossRef Peterson CA, Eurell JA, Erdman JJ (1995) Alterations in calcium intake on peak bone mass in the female rat. J Bone Miner Res 10:81–95PubMedCrossRef
11.
go back to reference Sengupta S, Arshad M, Sharma S, Dubey M, Singh MM (2005) Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague–Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management. J Steroid Biochem Mol Biol 94:421–429PubMedCrossRef Sengupta S, Arshad M, Sharma S, Dubey M, Singh MM (2005) Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague–Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management. J Steroid Biochem Mol Biol 94:421–429PubMedCrossRef
12.
go back to reference Li G, Zhang XA, Zhang JF, Chan CY, Yew DT, He ML, Lin MC, Leung PC, Kung HF (2010) Ethanol extract of Fructus ligustri lucidi promotes osteogenesis of mesenchymal stem cells. Phytother Res 24:571–576PubMed Li G, Zhang XA, Zhang JF, Chan CY, Yew DT, He ML, Lin MC, Leung PC, Kung HF (2010) Ethanol extract of Fructus ligustri lucidi promotes osteogenesis of mesenchymal stem cells. Phytother Res 24:571–576PubMed
14.
15.
go back to reference Fleet JC, Schoch RD (2010) Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci 47:181–195PubMedCentralPubMedCrossRef Fleet JC, Schoch RD (2010) Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci 47:181–195PubMedCentralPubMedCrossRef
16.
19.
go back to reference Friedman AW (2006) Important determinants of bone strength: beyond bone mineral density. J Clin Rheumatol 12:70–77PubMedCrossRef Friedman AW (2006) Important determinants of bone strength: beyond bone mineral density. J Clin Rheumatol 12:70–77PubMedCrossRef
20.
21.
go back to reference Chen H, Zhou X, Fujita H, Onozuka M, Kubo KY (2013) Age-related changes in trabecular and cortical bone microstructure. Int J Endocrinol 2013:213234PubMedCentralPubMed Chen H, Zhou X, Fujita H, Onozuka M, Kubo KY (2013) Age-related changes in trabecular and cortical bone microstructure. Int J Endocrinol 2013:213234PubMedCentralPubMed
22.
go back to reference Srivastava K, Khan K, Tyagi AM, Khan MP, Yadav DK, Trivedi R, Maurya R, Singh D, Chattopadhyay N (2013) Greater skeletal gains in ovary intact rats at maturity are achieved by Supplementing a standardized extract of Butea monosperma stem bark that confers better bone conserving effect following ovariectomy and concurrent treatment withdrawal. Evid Based Complement Alternat Med 2013:519387PubMedCentralPubMed Srivastava K, Khan K, Tyagi AM, Khan MP, Yadav DK, Trivedi R, Maurya R, Singh D, Chattopadhyay N (2013) Greater skeletal gains in ovary intact rats at maturity are achieved by Supplementing a standardized extract of Butea monosperma stem bark that confers better bone conserving effect following ovariectomy and concurrent treatment withdrawal. Evid Based Complement Alternat Med 2013:519387PubMedCentralPubMed
23.
go back to reference Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JM, Garcia-Garcia A (2010) RANK/RANKL/OPG role in distraction osteogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:679–686PubMedCrossRef Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JM, Garcia-Garcia A (2010) RANK/RANKL/OPG role in distraction osteogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:679–686PubMedCrossRef
24.
go back to reference Bai YD, Yang FS, Xuan K, Bai YX, Wu BL (2008) Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med Hypotheses 71:256–258PubMedCrossRef Bai YD, Yang FS, Xuan K, Bai YX, Wu BL (2008) Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med Hypotheses 71:256–258PubMedCrossRef
25.
27.
go back to reference Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495PubMedCrossRef Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495PubMedCrossRef
28.
go back to reference Lee YS, Choi EM (2011) Costunolide stimulates the function of osteoblastic MC3T3-E1 cells. Int Immunopharmacol 11:712–718PubMedCrossRef Lee YS, Choi EM (2011) Costunolide stimulates the function of osteoblastic MC3T3-E1 cells. Int Immunopharmacol 11:712–718PubMedCrossRef
29.
go back to reference Li F, Yang Y, Zhu P, Chen W, Qi D, Shi X, Zhang C, Yang Z, Li P (2012) Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia 83:1443–1450PubMedCrossRef Li F, Yang Y, Zhu P, Chen W, Qi D, Shi X, Zhang C, Yang Z, Li P (2012) Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia 83:1443–1450PubMedCrossRef
30.
go back to reference Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420PubMedCrossRef Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420PubMedCrossRef
31.
go back to reference Malaval L, Modrowski D, Gupta AK, Aubin JE (1994) Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158:555–572PubMedCrossRef Malaval L, Modrowski D, Gupta AK, Aubin JE (1994) Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158:555–572PubMedCrossRef
32.
go back to reference Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893–903PubMedCrossRef Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893–903PubMedCrossRef
33.
go back to reference Li JF, Chen SJ, Zhao Y, Li JX (2009) Glycoside modification of oleanolic acid derivatives as a novel class of anti-osteoclast formation agents. Carbohydr Res 344:599–605PubMedCrossRef Li JF, Chen SJ, Zhao Y, Li JX (2009) Glycoside modification of oleanolic acid derivatives as a novel class of anti-osteoclast formation agents. Carbohydr Res 344:599–605PubMedCrossRef
34.
go back to reference Li JF, Zhao Y, Cai MM, Li XF, Li JX (2009) Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity. Eur J Med Chem 44:2796–2806PubMedCrossRef Li JF, Zhao Y, Cai MM, Li XF, Li JX (2009) Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity. Eur J Med Chem 44:2796–2806PubMedCrossRef
35.
go back to reference Zhang Y, Li JX, Zhao J, Wang SZ, Pan Y, Tanaka K, Kadota S (2005) Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorg Med Chem Lett 15:1629–1632PubMedCrossRef Zhang Y, Li JX, Zhao J, Wang SZ, Pan Y, Tanaka K, Kadota S (2005) Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorg Med Chem Lett 15:1629–1632PubMedCrossRef
36.
go back to reference Xu Y, Han X, Li Y (2010) Effect of marine collagen peptides on long bone development in growing rats. J Sci Food Agric 90:1485–1491PubMedCrossRef Xu Y, Han X, Li Y (2010) Effect of marine collagen peptides on long bone development in growing rats. J Sci Food Agric 90:1485–1491PubMedCrossRef
Metadata
Title
Fructus Ligustri Lucidi (FLL) ethanol extract increases bone mineral density and improves bone properties in growing female rats
Authors
Ying Lyu
Xin Feng
Pengling Zhao
Zhenghao Wu
Hao Xu
Yuehui Fang
Yangfeng Hou
Liya Denney
Yajun Xu
Haotian Feng
Publication date
01-11-2014
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2014
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-013-0536-8

Other articles of this Issue 6/2014

Journal of Bone and Mineral Metabolism 6/2014 Go to the issue

List of Reviewers 2013-2014

List of reviewers 2013–2014

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.